Interference of nonsteroidal antiinflammatory drugs with very late activation antigen 4/vascular cells adhesion molecule 1-mediated lymphocyte-endothelial cell adhesion.

OBJECTIVE To study the effect of nonsteroidal antiinflammatory drugs (NSAIDs) on the adhesion of peripheral blood lymphocytes (PBL) to activated human umbilical vein endothelial cells (HUVEC) under conditions that resemble blood flow. METHODS Assays of adhesion of PBL to HUVEC or recombinant vascular cell adhesion molecule 1 (rVCAM-1), intercellular adhesion molecule 1 (ICAM-1), and E-selectin were performed under continuous rotation at 37 degrees C. The phenotype of PBL subpopulations attached was characterized by flow cytometry. Lymphocytes were pretreated with different doses (5-100 microg/ml) of aceclofenac, diclofenac, indomethacin, or piroxicam or with inhibitory monoclonal antibodies (MAb) prior to the adhesion assays. The effect of NSAIDs on lymphocyte adhesion molecules was assessed by flow cytometry. To determine whether NSAIDs interfere with the affinity state of very late activation antigen 4 (VLA-4) integrin, we studied the effect of these drugs on the appearance of a beta1 activation-dependent epitope recognized by the HUTS21 MAb both on human T lymphoblasts and on synovial fluid lymphocytes (SFL). RESULTS In the flow-resembling model, PBL-HUVEC adhesion was mainly mediated by the VLA-4/ VCAM-1 adhesion pathway. The major PBL subset attached was the CD3+, CD45RO+ memory T cell, with CD49d(high) expression. Aceclofenac, diclofenac, and indomethacin, but not piroxicam, were able to inhibit PBL adhesion to HUVEC or rVCAM-1. However, the quantitative expression of VLA-4 was not affected by treatment of PBL with any of the NSAIDs studied. On T lymphoblasts and SFL, mostly CD45RO+ cells, the expression of the beta1 activation-dependent epitope detected by HUTS21 MAb was significantly decreased by aceclofenac, diclofenac, and indomethacin. CONCLUSION Some NSAIDs are able to inhibit the adhesion of PBL to HUVEC under conditions that resemble blood flow by interfering with the conformational change in VLA-4 that increases its affinity for VCAM-1.

[1]  F. Luscinskas,et al.  CD45RA-RO+ (memory) but not CD45RA+RO- (naive) T cells roll efficiently on E- and P-selectin and vascular cell adhesion molecule-1 under flow. , 1997, Journal of immunology.

[2]  L. Moreland,et al.  Biologic agents for treating rheumatoid arthritis. Concepts and progress. , 1997, Arthritis and rheumatism.

[3]  N. Hogg,et al.  Functional relevance during lymphocyte migration and cellular localization of activated β1 integrins , 1997 .

[4]  M. Ahern,et al.  Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression. , 1996, Arthritis and rheumatism.

[5]  C. Cabañas,et al.  Activated Conformations of Very Late Activation Integrins Detected by a Group of Antibodies (HUTS) Specific for a Novel Regulatory Region(355425) of the Common 1 Chain (*) , 1996, The Journal of Biological Chemistry.

[6]  P. Kubes,et al.  The alpha 4-integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo , 1996, The Journal of experimental medicine.

[7]  C. Featherstone.  Anti-integrin drugs developed to treat inflammation , 1996, The Lancet.

[8]  F. Sánchez‐Madrid,et al.  Aceclofenac, a new nonsteroidal antiinflammatory drug, decreases the expression and function of some adhesion molecules on human neutrophils. , 1996, The Journal of rheumatology.

[9]  S. McColl,et al.  Inhibition of lymphocyte adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. , 1996, Arthritis and rheumatism.

[10]  G. Weissmann,et al.  Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. , 1995, The Journal of clinical investigation.

[11]  F. Sánchez‐Madrid,et al.  Expression and functional significance of an activation‐dependent epitope of the β1 integrins in chronic inflammatory diseases , 1995, European journal of immunology.

[12]  F. Sánchez‐Madrid,et al.  Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. , 1995, The Journal of clinical investigation.

[13]  F. Luscinskas,et al.  P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow , 1995, The Journal of experimental medicine.

[14]  E. Berg,et al.  α4 integrins mediate lymphocyte attachment and rolling under physiologic flow , 1995, Cell.

[15]  S. Watson,et al.  Entry of naive CD4 T cells into peripheral lymph nodes requires L- selectin , 1994, The Journal of experimental medicine.

[16]  L. McIntire,et al.  A two-step adhesion cascade for T cell/endothelial cell interactions under flow conditions. , 1994, The Journal of clinical investigation.

[17]  C. Boitard,et al.  Recirculation, phenotype and functions of lymphocytes in mice treated with monoclonal antibody MEL‐14 , 1994, European journal of immunology.

[18]  F. Sánchez‐Madrid,et al.  Regulation of ICAM‐3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism , 1994, European journal of immunology.

[19]  F. Sánchez‐Madrid,et al.  ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands , 1994, The Journal of cell biology.

[20]  N. Miyasaka,et al.  Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells. , 1994, Molecular pharmacology.

[21]  S. Ghosh,et al.  Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.

[22]  T. Edgington,et al.  Monoclonal antibody to an activation neoepitope of alpha M beta 2 inhibits multiple alpha M beta 2 functions. , 1994, Journal of immunology.

[23]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[24]  J. Travis.  Biotech gets a grip on cell adhesion. , 1993, Science.

[25]  L. Picker,et al.  Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. , 1993, Journal of immunology.

[26]  L. Picker,et al.  Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. , 1993, Journal of immunology.

[27]  G. Weissmann,et al.  The adhesion molecules of inflammation. , 1993 .

[28]  A Etzioni,et al.  Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. , 1992, The New England journal of medicine.

[29]  F. Sánchez‐Madrid,et al.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). , 1992, The Journal of clinical investigation.

[30]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[31]  C. Mackay,et al.  Tissue‐specific migration pathways by phenotypically distinct subpopulations of memory T cells , 1992, European journal of immunology.

[32]  A. Craig,et al.  The binding site on ICAM-1 for plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site , 1992, Cell.

[33]  E. Butcher.  Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity , 1991, Cell.

[34]  F. Luscinskas,et al.  Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. , 1991, Journal of immunology.

[35]  B. Kirkham,et al.  Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. , 1991, The Journal of rheumatology.

[36]  C. Benjamin,et al.  Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1. , 1991, Biochemical and biophysical research communications.

[37]  S. Bixler,et al.  Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1. , 1991, Journal of immunology.

[38]  R. Day,et al.  Nonsteroidal antiinflammatory drugs--differences and similarities. , 1991, The New England journal of medicine.

[39]  A. Frelinger,et al.  Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. , 1990, The Journal of biological chemistry.

[40]  S. Abramson,et al.  The mechanisms of action of nonsteroidal antiinflammatory drugs. , 1989, Arthritis and rheumatism.

[41]  F. Sánchez‐Madrid,et al.  Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes , 1988, The Journal of experimental medicine.

[42]  P. Lipsky,et al.  Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[43]  A. Frelinger,et al.  Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. , 1988, The Journal of biological chemistry.

[44]  G. Janossy,et al.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. , 1988, Journal of immunology.

[45]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[46]  J. Minta,et al.  Some nonsteroidal antiinflammatory drugs inhibit the generation of superoxide anions by activated polymorphs by blocking ligand-receptor interactions. , 1985, The Journal of rheumatology.

[47]  B. Coller.  A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. , 1985, The Journal of clinical investigation.

[48]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[49]  C. Cabañas,et al.  Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family. , 1997, Arthritis and rheumatism.

[50]  M. Schwartz,et al.  Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.

[51]  Y. Tanaka,et al.  Lymphocyte interactions with endothelial cells. , 1992, Immunology today.

[52]  T. Springer,et al.  Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. , 1987, Annual review of medicine.